Riverhead Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $312K | Hold |
|
|||||
|
2019
Q2 | $358K | Buy |
|
|||||
|
2019
Q1 | $356K | Hold |
|
|||||
|
2018
Q4 | $385K | Hold |
|
|||||
|
2018
Q3 | $778K | Hold |
|
|||||
|
2018
Q2 | $587K | Hold |
|
|||||
|
2018
Q1 | $468K | Hold |
|
|||||
|
2017
Q4 | $388K | Buy |
|
|||||
|
2017
Q3 | $304K | Buy |
|
|||||
|
2017
Q2 | $218K | Buy |
|
|||||
|
2017
Q1 | $95K | Buy |
|
|||||
|
2016
Q4 | $81K | Hold |
|
|||||
|
2016
Q3 | $82K | Sell |
|
|||||
|
2016
Q2 | $608K | Buy |
|
|||||
|
2016
Q1 | $340K | Sell |
|
|||||
|
2015
Q4 | $390K | Buy |
|
|||||
|
2015
Q3 | $94K | Buy |
|